Upcoming Visits

Upcoming FDA Visits:

Dates Topic FDA Visitors

September 20-22, 2017

 

Personalized Medicine and Molecular Genetics

 

David Litwack, PhD | Personalized Medicine Staff, OIR/CDRH
Hisani Madison, PhD, MPH | Biologist, Division of Molecular Genetics and Pathology, OIR/CDRH
Reena Philip, PhD | Director, Division of Molecular Genetics and Pathology, OIR/CDRH
Brittany Schuck, PhD | Senior Staff Fellow, Division of Chemistry and Toxicology Devices, OIR/CDRH

 

October 2-3, 2017

CRISPR/Cas9 Genome Editing

Ying Huang, PhD | Pharmacologist, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER
Jakob Reiser, PhD | Principal Investigator, Division of Cellular & Gene Therapies/OTAT, CBER

 

November 15-16, 2017

Cellular Immunotherapies

Kristin Baird, MD | Medical Officer, Division of Clinical Evaluation & Pharmacology/Toxicology/OTAT, CBER
Graeme Price, PhD | Research Microbiologist, Division of Cellular & Gene Therapies/OTAT, CBER

 

TBD

Global Substance Registration System

Larry Callahan, PhD | Lead Scientist- Substance Registration System, Office of Health Informatics, OCS
Leslie Kenna, PhD | Pharmacologist, Division of Scientific Support, Office of New Animal Drug Evaluation, CVM

 

Public lectures are posted under the "Events" link on the left menu bar.  Please contact Lawrence Lin to learn more about any of the upcoming visits.